Landon H Tompkins1, Barry N Gellman2, Steven R Prina3, Gino F Morello4, Thomas Roussel1, Jonathan A Kopechek1, Stuart J Williams5, Priscilla C Petit2, Mark S Slaughter6, Steven C Koenig7,8, Kurt A Dasse9,10,11. 1. Department of Bioengineering, University of Louisville, Louisville, KY, 40202, USA. 2. Inspired Therapeutics LLC, 125 E. Merritt Island Cswy, #107-341, Merritt Island, FL, 32925, USA. 3. BLDC Designs LLC, Rocklin, CA, 95677, USA. 4. Veritium Research LLC, Fort Lee, NJ, 07024, USA. 5. Department of Mechanical Engineering, University of Louisville, Louisville, KY, 40202, USA. 6. Department of Cardiovascular and Thoracic Surgery, University of Louisville, Louisville, KY, 40202, USA. 7. Department of Bioengineering, University of Louisville, Louisville, KY, 40202, USA. steven.koenig@louisville.edu. 8. Department of Cardiovascular and Thoracic Surgery, University of Louisville, Louisville, KY, 40202, USA. steven.koenig@louisville.edu. 9. Department of Bioengineering, University of Louisville, Louisville, KY, 40202, USA. kdasse@inspiredtherapeuticsllc.com. 10. Inspired Therapeutics LLC, 125 E. Merritt Island Cswy, #107-341, Merritt Island, FL, 32925, USA. kdasse@inspiredtherapeuticsllc.com. 11. Department of Cardiovascular and Thoracic Surgery, University of Louisville, Louisville, KY, 40202, USA. kdasse@inspiredtherapeuticsllc.com.
Abstract
PURPOSE: Pediatric heart failure patients remain in critical need of a dedicated mechanical circulatory support (MCS) solution as development efforts for specific pediatric devices continue to fall behind those for the adult population. The Inspired Pediatric VAD is being developed as a pediatric specific MCS solution to provide up to 30-days of circulatory or respiratory support in a compact modular package that could allow for patient ambulation during treatment. METHODS: Hydrodynamic performance (flows, pressures), impeller/rotor mechanical properties (torques, forces), and flow shear stress and residence time distributions of the latest design version, Inspired Pediatric VAD V3, were numerically predicted and investigated using computational fluid dynamics (CFD) software (SolidWorks Flow Simulator). RESULTS: Hydrodynamic performance was numerically predicted, indicating no change in flow and pressure head compared to the previous device design (V2), while displaying increased impeller/rotor torques and translation forces enabled by improved geometry. Shear stress and flow residence time volumetric distributions are presented over a range of pump rotational speeds and flow rates. At the lowest pump operating point (3000 RPM, 0.50 L/min, 75 mmHg), 79% of the pump volume was in the shear stress range of 0-10 Pa with < 1% of the volume in the critical range of 150-1000 Pa for blood damage. At higher speed and flow (5000 RPM, 3.50 L/min, 176 mmHg), 65% of the volume resided in the 0-10 Pa range compared to 2.3% at 150-1000 Pa. CONCLUSIONS: The initial computational characterization of the Inspired Pediatric VAD V3 is encouraging and future work will include device prototype testing in a mock circulatory loop and acute large animal model.
PURPOSE: Pediatric heart failure patients remain in critical need of a dedicated mechanical circulatory support (MCS) solution as development efforts for specific pediatric devices continue to fall behind those for the adult population. The Inspired Pediatric VAD is being developed as a pediatric specific MCS solution to provide up to 30-days of circulatory or respiratory support in a compact modular package that could allow for patient ambulation during treatment. METHODS: Hydrodynamic performance (flows, pressures), impeller/rotor mechanical properties (torques, forces), and flow shear stress and residence time distributions of the latest design version, Inspired Pediatric VAD V3, were numerically predicted and investigated using computational fluid dynamics (CFD) software (SolidWorks Flow Simulator). RESULTS: Hydrodynamic performance was numerically predicted, indicating no change in flow and pressure head compared to the previous device design (V2), while displaying increased impeller/rotor torques and translation forces enabled by improved geometry. Shear stress and flow residence time volumetric distributions are presented over a range of pump rotational speeds and flow rates. At the lowest pump operating point (3000 RPM, 0.50 L/min, 75 mmHg), 79% of the pump volume was in the shear stress range of 0-10 Pa with < 1% of the volume in the critical range of 150-1000 Pa for blood damage. At higher speed and flow (5000 RPM, 3.50 L/min, 176 mmHg), 65% of the volume resided in the 0-10 Pa range compared to 2.3% at 150-1000 Pa. CONCLUSIONS: The initial computational characterization of the Inspired Pediatric VAD V3 is encouraging and future work will include device prototype testing in a mock circulatory loop and acute large animal model.
Authors: Anne I Dipchand; Joseph W Rossano; Leah B Edwards; Anna Y Kucheryavaya; Christian Benden; Samuel Goldfarb; Bronwyn J Levvey; Lars H Lund; Bruno Meiser; Roger D Yusen; Josef Stehlik Journal: J Heart Lung Transplant Date: 2015-08-28 Impact factor: 10.247
Authors: Pramote Hochareon; Keefe B Manning; Arnold A Fontaine; John M Tarbell; Steven Deutsch Journal: ASAIO J Date: 2004 Nov-Dec Impact factor: 2.872
Authors: L Wiegmann; S Boës; D de Zélicourt; B Thamsen; M Schmid Daners; M Meboldt; V Kurtcuoglu Journal: Ann Biomed Eng Date: 2017-11-01 Impact factor: 3.934
Authors: Joseph W Rossano; Jeffrey J Kim; Jamie A Decker; Jack F Price; Farhan Zafar; Daniel E Graves; David L S Morales; Jeffrey S Heinle; Biykem Bozkurt; Jeffrey A Towbin; Susan W Denfield; William J Dreyer; John L Jefferies Journal: J Card Fail Date: 2012-04-10 Impact factor: 5.712
Authors: M Colvin; J M Smith; M A Skeans; L B Edwards; K Uccellini; J J Snyder; A K Israni; B L Kasiske Journal: Am J Transplant Date: 2017-01 Impact factor: 8.086